Solesence, Inc. Common Stock (SLSN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has a cash flow conversion efficiency ratio of 0.103x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.82 Million) by net assets ($17.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Solesence, Inc. Common Stock balance sheet independence to measure how much of total assets are equity-financed.
Solesence, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Solesence, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Solesence, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Solesence, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solesence, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pancontinental Energy NL
AU:PCL
|
-0.064x |
|
Mesa Air Group Inc
NASDAQ:MESA
|
0.054x |
|
Mastermyne Group Ltd
AU:MYE
|
0.071x |
|
Meta Biomed Co. Ltd
KQ:059210
|
0.009x |
|
Campina Ice Cream Industry Tbk PT
JK:CAMP
|
0.086x |
|
AmFIRST Real Estate Investment Trust
KLSE:5120
|
0.013x |
|
DIVA Laboratories Ltd
TWO:4153
|
0.005x |
|
Labiana Health S.A.
MC:LAB
|
1.298x |
Annual Cash Flow Conversion Efficiency for Solesence, Inc. Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Solesence, Inc. Common Stock from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see Solesence, Inc. Common Stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $17.63 Million | $-8.57 Million | -0.486x | -468.40% |
| 2024-12-31 | $14.95 Million | $1.97 Million | 0.132x | +112.50% |
| 2023-12-31 | $1.90 Million | $-2.01 Million | -1.055x | -261.08% |
| 2022-12-31 | $5.65 Million | $-1.65 Million | -0.292x | -193.94% |
| 2021-12-31 | $7.46 Million | $2.32 Million | 0.311x | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingre… Read more